INTERNATIONAL PATENT: VERVE THERAPEUTICS, INC. FILES APPLICATION FOR "IN VIVO NICKASE-BASED EDITING OF THE ANGIOTENSINOGEN GENE"

GENEVA, Feb. 18 -- VERVE THERAPEUTICS, INC. (201 Brookline AvenueSuite 601Boston, Massachusetts 02215) filed a patent application (PCT/US2025/041143) for "IN VIVO NICKASE-BASED EDITING OF THE ANGIOTENSINOGEN GENE" on Aug 07, 2025. With publication no. WO/2026/035968, the details related to the patent application was published on Feb 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DE ALMEIDA PINTO GARCIA, Sara Cristina (201 Brookline AvenueSuite 601Boston, Massachusetts 02215), JIAO, Yang (201 Brookline AvenueSuite 601Boston, Massachusetts 02215), CORNELL, Liam (201 Brookline AvenueSuite ...